| Title | Leukemia and Lymphoma |
| Standard Abbreviation | Leuk. Lymphoma |
| Type of Publication | Journal |
| Discipline | Hematology (Q2); Oncology (Q2); Cancer Research (Q3) |
| Impact Score | 1.65 |
| SCImago Journal Rank (SJR) | 0.837 |
| h-index | 99 |
| Overall Rank | 5592 |
| Publisher Name | Informa Healthcare |
| Publication Country | United Kingdom |
| International Standard Serial Number (ISSN) | 10292403, 10428194 |
| Coverage and History | 1989-2022 |
| Best Quartile | Q2 |
| Total Citations Received (Last 3 Year) |
2564 |
Leukemia and Lymphoma is a journal published by Informa Healthcare. This journal covers the area[s] related to Hematology, Oncology, Cancer Research, etc.
The coverage history of this journal is as follows: 1989-2022.
The rank of this journal is 5592. This journal's impact score, h-index, and SJR are 1.65, 99, and 0.837, respectively. The ISSN of this journal is/are as follows: 10292403, 10428194.
The best quartile of Leukemia and Lymphoma is Q2.
This journal has received a total of 2564 citations during the last three years (Preceding 2022).
The latest impact score (IS) of the Leukemia and Lymphoma is 1.65. It is computed in the year 2023 as per its definition and based on Scopus data.
1.65
It is decreased by a factor of around 0.05, and the percentage change is -2.94% compared to the preceding year 2021, indicating a falling trend.
The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact Score 2022 of Leukemia and Lymphoma is 1.65. If a similar downward trend continues, IS may decrease in 2023 as well.
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 1.65 |
| 2021 | 1.70 |
| 2020 | 1.74 |
| 2019 | 1.67 |
| 2018 | 1.56 |
| 2017 | 1.53 |
| 2016 | 1.61 |
| 2015 | 1.90 |
| 2014 | 1.90 |
The h-index of Leukemia and Lymphoma is 99. By definition of the h-index, this journal has at least 99 published articles with more than 99 citations.
The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.
The International Standard Serial Number (ISSN) of Leukemia and Lymphoma is/are as follows: 10292403, 10428194.
The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.
ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}
The Leukemia and Lymphoma is ranked 5592 among 27955 Journals, Conferences, and Book Series.
As per SJR, this journal is ranked 0.837.
SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
The publisher of Leukemia and Lymphoma is Informa Healthcare. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 1989-2022.
Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).
The International Organization for Standardization 4 (ISO 4) abbreviation of Leukemia and Lymphoma is Leuk. Lymphoma. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).
As ISO 4 is an international standard, the abbreviation ('Leuk. Lymphoma') can be used for citing, indexing, abstraction, and referencing purposes.
If your area of research or discipline is related to Hematology, Oncology, Cancer Research, etc., please check the journal's official website to understand the complete publication process.
There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:
The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.
The latest impact score of Leukemia and Lymphoma is 1.65. It is computed in the year 2023.
The latest h-index of Leukemia and Lymphoma is 99. It is evaluated in the year 2023.
The latest SCImago Journal Rank (SJR) of Leukemia and Lymphoma is 0.837. It is calculated in the year 2023.
The latest ranking of Leukemia and Lymphoma is 5592. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.
Leukemia and Lymphoma is published by Informa Healthcare. The publication country of this journal is United Kingdom.
This standard abbreviation of Leukemia and Lymphoma is Leuk. Lymphoma.
Leukemia and Lymphoma is a journal published by Informa Healthcare.
The scope of Leukemia and Lymphoma is as follows:
For detailed scope of Leukemia and Lymphoma, check the official website of this journal.
The International Standard Serial Number (ISSN) of Leukemia and Lymphoma is/are as follows: 10292403, 10428194.
The best quartile for Leukemia and Lymphoma is Q2.
The coverage history of Leukemia and Lymphoma is as follows 1989-2022.
Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
| Journal/Conference/Book Title | Type | Publisher | Ranking | SJR | h-index | Impact Score |
|---|---|---|---|---|---|---|
| International Journal of Mathematical Education in Science and Technology | Journal | Taylor and Francis Ltd. | 10040 | 39 | 1.33 | |
| Materials Research | Journal | Universidade Federal de Sao Carlos | 14791 | 65 | 1.62 | |
| Journal of Sociolinguistics | Journal | Wiley-Blackwell Publishing Ltd | 5409 | 61 | 1.96 | |
| Educational Measurement: Issues and Practice | Journal | Wiley-Blackwell Publishing Ltd | 4494 | 59 | 1.53 | |
| Proceedings of the Technical Association of the Graphic Arts, TAGA | Conference And Proceedings | Technical Association of the Graphic | 30903 | 8 | 0.00 | |
| Archiv fur Geflugelkunde | Journal | Verlag Eugen Ulmer | 28770 | 30 | 0.00 | |
| Journal of Sociology | Journal | SAGE Publications Ltd | 6009 | 58 | 3.21 | |
| Expert Review of Clinical Pharmacology | Journal | Taylor and Francis Ltd. | 5241 | 53 | 4.10 | |
| Poljoprivreda | Journal | Faculty of Agriculture in Osijek | 20724 | 14 | 0.67 | |
| Psycho-Oncologie | Journal | Springer Paris | 24009 | 11 | 0.13 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Updated Soon |
| 2022 | 1.65 |
| 2021 | 1.70 |
| 2020 | 1.74 |
| 2019 | 1.67 |
| 2018 | 1.56 |
| 2017 | 1.53 |
| 2016 | 1.61 |
| 2015 | 1.90 |
| 2014 | 1.90 |
1.65
0.837
99
5592
